Leading with Science and Heart: Dr. Ross Breckenridge on Building a Resilient Biotech
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Dr. Ross Breckenridge, CEO of Arjuna Therapeutics, a company pioneering a novel approach to precision oncology through therapeutic molecular clusters. Dr. Breckenridge shares insights on the cultural differences between academia and industry, the benefits of conducting clinical trials in Europe over the U.S., and the importance of chemistry manufacturing controls (CMC) in drug development. He also discusses the challenges of raising capital and the critical role of strong leadership to build and foster a resilient and reliable team. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen.Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Maddy Foley and our production assistant is Joia Putnoi.
--------
35:37
Bedside to Biotech: Dr. Sam Blackman on Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Sam Blackman, co-founder and former Chief Medical Officer of Day One Biopharmaceuticals, board member of the Pediatric Brain Tumor Foundation, Bonum Therapeutics and CureSearch for Children's Cancer, and the new Entrepreneur in Residence at Google Ventures. Sam talks about his career journey from physician to biotech executive, and navigating the complexities of clinical trials, especially within pediatric oncology. He also discusses the critical need to connect the science, patients, and investment thesis together into a coherent story when fundraising in drug development. 2:37 - How he was pulled to pediatric medicine6:00 - His decision to transition into drug development to impact exponentially more patients.16:40 - The importance of connecting you vision to your company name26:04 - How making those risky decisions in drug development can have profound impacts on patient outcomes40:00 - The Power of Storytelling in Science and Business47:57 - Advice for biotech entrepreneurs seeking capital We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen.Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Maddy Foley and our production assistant is Joia Putnoi.
--------
52:50
From Mentee to CEO, Board Member and Mentor: Insights from Kerrie Brady
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Kerrie Brady, Chairperson of Neurocentrx Pharmaceuticals and an Independent Board Member at Asklepion Pharmaceuticals and Invea Therapeutics. Kerrie reflects on her extensive career in the biotech and pharmaceutical industries, highlighting the importance of mentorship, leadership style, and navigating cultural transitions in global business. Kerrie also shares her insights on the complexities of board membership and the challenges of maintaining work-life balance in this fast-paced industry.We hope you enjoyed this episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen.Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Maddy Foley and our production assistant is Joia Putnoi.
--------
37:33
Leading Through Setbacks with Cytokinetics’ Robert Blum
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
--------
36:30
De-Risking Clinical Trials: Michael Bailey's Patient-First Approach
In this episode of Clinical Trialblazers, Michael Bailey, President and CEO of Aveo Oncology, shares his insights on the evolving landscape of oncology trials and their impact on patient care. Join host Alberto Grignolo for a thoughtful conversation on the challenges and innovations shaping the future of clinical development.We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen.Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Maddy Foley and our production assistant is Joia Putnoi.
Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
Deutschland